Fig. 6From: The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradoxKi-67 (proliferation marker, panels a and b), CD31 (measure of vascularity, panels c and d) and cleaved caspase 3 (apoptosis marker, panels e and f) immunohistochemical staining of tumour sections at day 21 from control mice (left) and mice treated with β-OHB (500 mg/kg), injected ip daily for 3 weeks (right) (Bars show 100 μm). See Table 1 for quantitative analysisBack to article page